Clinical Trials Sponsored by Istituto Auxologico Italiano

Total 337 results

Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Azienda Ospedaliero, Universitaria Pisana; Istituto Auxologico Italiano; Azienda... and other collaborators

Recruiting

Tocilizumab in Active Moderate-severe Graves' Orbitopathy (TOGO)

Graves Ophthalmopathy

Italy
University of Barcelona
Hospital Universitari de Bellvitge; Istituto Auxologico Italiano; Hospital Universitari... and other collaborators

Completed

Virtual Reality Based Cue-exposure Treatment for Bulimia Nervosa

Binge-Eating Disorder | Bulimia Nervosa | Binge Eating

Spain, Italy
University of Barcelona
Hospital Clinic of Barcelona; Hospital Universitari de Bellvitge; Istituto Auxologico... and other collaborators

Terminated

Treating the Fear of Gaining Weight in Anorexia Nervosa

Anorexia Nervosa

Spain
I.R.C.C.S. Fondazione Santa Lucia
IRCCS San Raffaele; Istituto Auxologico Italiano; University of Genova; IRCCS National... and other collaborators

Completed

Efficacy of Proprioceptive Focal Stimulation (EQUISTASI) on Gait Parameters in Parkinson. Italian Multicentric Study (PAGE)

Parkinson Disease | Gait, Shuffling | Effects of Vibration

Italy
Italian Institute of Telemedicine
Italian Society of Hypertension; Italian Society of General Practitioners; Biotechmed...

Recruiting

Telemonitoring of Blood Pressure in Local Pharmacies (TEMPLAR)

Hypertension

Italy
Italian Institute of Telemedicine
BPLab

Completed

International Registry for Ambulatory Blood Pressure and Arterial Stiffness Telemonitoring (VASOTENS)

Hypertension

Russian Federation, Argentina, Armenia, Australia, Italy, Kazakhstan, Mexico, Portugal, Romania, Ukraine
University of Turin, Italy
University of Messina; Istituto Auxologico Italiano; Ministry of Health, Italy; A.O.U. Città della Salute e della Scienza - Molinette Hospital

Recruiting

CCT for Comprehensive Risk Stratification Following STEMI (CT-STEMI)

Myocardial Infarction

Italy
Regina Elena Cancer Institute
University of Pisa; University of Roma La Sapienza; University of Turin, Italy; Istituto Oncologico Veneto IRCCS and other collaborators

Recruiting

Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer (Gisel)

Differentiated Thyroid Cancer | Gender

Italy
University Hospital of Ferrara
Istituto Italiano di Tecnologia

Completed

Action Observation Training for Upper Limb Rehabilitation in Stroke Patients

Stroke Rehabilitation

Italy
Istituto Clinico Humanitas
Agenzia Italiana del Farmaco

Unknown

Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis (SCILLA)

Colitis, Ulcerative

Italy
Fondazione Italiana Linfomi ONLUS
Istituto Clinico Humanitas

Terminated

Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or Refractory

Hodgkin's Lymphoma

Italy
Gruppo Italiano Mammella (GIM)

Unknown

Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy

Breast Cancer

Italy
Gruppo Italiano Carcinoma Renale

Unknown

Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer

Italy
Gruppo Italiano Mammella (GIM)

Completed

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

Breast Cancer

Italy
Fondazione Don Carlo Gnocchi Onlus
Istituto Italiano di Tecnologia

Recruiting

ACTive Exoskeleton for Unilaterally-Assisted Locomotion (ACTUAL) (ACTUAL)

Stroke Sequelae | Gait, Hemiplegic

Italy
Istituto Nazionale Assicurazione contro gli Infortuni...
Istituto Italiano di Tecnologia

Completed

Usability and Acceptance of a New Robotic Exoskeleton for Shoulder Rehabilitation (CRMINAIL08)

Shoulder Injuries and Disorders

Italy
Istituto Nazionale Assicurazione contro gli Infortuni...
Istituto Italiano di Tecnologia

Completed

Robot-assisted Rehabilitation of Ankle Fractures: Efficacy and Comparison With Traditional Methods

Ankle Fractures

Italy
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Istituto Clinico Humanitas

Completed

Efficacy and Safety of Luspatercept: A Study by Fondazione Italiana Sindromi Mielodisplastiche (FISiM-Luspa)

Myeloid Dysplasia

Italy
Istituto Nazionale Assicurazione contro gli Infortuni...
Istituto Italiano di Tecnologia

Completed

Robot-based Wrist Rehabilitation in Orthopaedics: Efficacy and Comparison With Traditional Methods

Wrist Injuries
Associazione Italiana Ematologia Oncologia Pediatrica
Istituto Giannina Gaslini

Recruiting

Prospective Study Registry of Peripheral Neuroblastic Tumours Presenting With Spinal Canal Involvement (SCI) (NB-SCI)

Neuroblastic Tumors

Italy
Istituti Tumori Giovanni Paolo II
Gruppo Oncologico Italiano di Ricerca Clinica; Gruppo Oncologico Italia Meridionale and other collaborators

Unknown

Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer (GIP-1)

Pancreatic Cancer

Italy
Gruppo Oncologico Italiano di Ricerca Clinica
Bioikos Ambiente Srl; Istituto Toscano Tumori; Temas srl; Mipharm S.p.A.; Bristol...

Active, not recruiting

Early Switch Maintenance vs Delayed Second-line Nivolumab in Advanced Stage Squamous Non-small Cell Lung Cancer (NSCLC) Patients (EDEN Trial) (EDEN)

Squamous Non-small Cell Lung Cancer

Italy
European Institute of Oncology
Agenzia Italiana del Farmaco

Recruiting

Neoadjuvant PRRT With Y-90-DOTATOC in pNET (NeoNet)

Pancreatic Neuroendocrine Tumor

Italy
Italian Sarcoma Group
Istituto Di Ricerche Farmacologiche Mario Negri

Completed

Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma (TRAVELL)

Leiomyosarcoma | Liposarcoma

Italy
Istituto Oncologico Veneto IRCCS
MSD Italia S.r.l.

Not yet recruiting

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study) (CHIMERA)

Pleural Mesothelioma

Italy
Istituto Oncologico Veneto IRCCS
BAYER S.p.A. - Italia

Completed

Regorafenib in Relapsed Glioblastoma (REGOMA)

Glioblastoma Multiforme

Italy
G. d'Annunzio University
Institute for Scientific Information on Coffee; Italian Istituto Nazionale...

Completed

Genetic Determinants of Cardiovascular Response to Coffee Drinking

Caffeine

Italy
Fondazione Poliambulanza Istituto Ospedaliero
Associazione Italiana per la Ricerca sul Cancro

Recruiting

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. (ADAPTA)

Ampullary Adenocarcinoma

Italy
Istituto Clinico Humanitas
Lega Italiana per la Lotta contro i Tumori

Terminated

The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography

Lung Cancer

Italy
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

MMF vs. AZA for Kidney Transplantation (ATHENA)

Kidney Transplant

Italy
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS) (NEMO)

Nephrotic Syndrome

Italy
Italian Sarcoma Group
AstraZeneca; PharmaMar; Istituto Di Ricerche Farmacologiche Mario Negri

Completed

Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS) (TOMAS)

Soft Tissue Sarcoma | Bone Tumor

Italy
Istituto Clinico Humanitas
Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva

Recruiting

Complexity and Frailty in Cardiothoracic and Vascular Anesthesia (CAfCA). Prospective Multicentric Observational Study (CAfCA)

Frailty | Anesthesia | Thoracic Surgery | Cardiothoracic Surgery | Vascular Surgery | Comorbidities and Coexisting Conditions

Italy
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis (ARCADIA)

Hypertension | Left Ventricular Hypertrophy

Italy
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Preventing ESRD in Overt Nephropathy of Type 2 Diabetes (VALID)

Diabetes

Italy, Slovenia
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

E-learning to Improve the Quality of Drug Prescribing in Hospitalized Elderly Patients

Drug Use
Istituti Clinici Scientifici Maugeri SpA
Società Italiana Cardiologia Ospedalità Accreditata (SICOA)

Recruiting

PAtients With Symptomatic Peripheral Artery Disease on Rivaroxaban-acetylsalicylic Acid Combination Therapy (PRO-PAS) (PRO-PAS)

Peripheral Atherosclerotic Disease

Italy
S. Andrea Hospital
Istituto Superiore di Sanità; Italian Multiple Sclerosis Foundation

Completed

Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis

Multiple Sclerosis

Italy
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Preventing Microalbuminuria in Type 2 Diabetes (VARIETY)

Diabetes

Italy
Istituti Clinici Scientifici Maugeri SpA
Società Italiana Cardiologia Ospedalità Accreditata (SICOA)

Recruiting

Therapeutic Strategy With Direct Oral Anticoagulants and Antiaggregant Drugs in Ischemic Heart Disease (PRODOAC)

Atrial Fibrillation

Italy
Istituto Giannina Gaslini
Pfizer; Agenzia Italiana del Farmaco; Compagnia di San Paolo

Recruiting

STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS (STARS)

Oligoarthritis, Juvenile | Polyarthritis, Juvenile, Rheumatoid Factor Negative

Italy
Fondazione Don Carlo Gnocchi Onlus
Istituto Italiano di Tecnologia; Istituto Nazionale di Ricovero e Cura per...

Not yet recruiting

Proof of Concept of Hybrid Robotics for Gait Rehabilitation of Persons Post-stroke (PoCH-Rehab)

Stroke Sequelae | Gait, Hemiplegic

Italy
ITAB - Institute for Advanced Biomedical Technologies
Italian Society of Cardiology

Completed

Italian Registry of Cardiovascular Magnetic Resonance on Congenital Anomalies of the Coronary Arteries (ITACA-Registry) (ITACA)

Congenital Coronary Artery Abnormality

Italy
European Institute of Oncology
Associazione Italiana per la Ricerca sul Cancro

Recruiting

Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer

Adenocarcinoma of Prostate

Italy
European Institute of Oncology
Associazione Italiana per la Ricerca sul Cancro

Completed

Promoting Weight Loss Through Diet and Exercise in Overweight Women With Breast Cancer (InForma)

Breast Cancer

Italy
European Institute of Oncology
Associazione Italiana per la Ricerca sul Cancro

Recruiting

MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer (MONDRIAN)

Lung Neoplasm Malignant

Italy
National Cancer Institute, Naples
Gruppo Oncologico Italia Meridionale; Gruppo Italiano per lo studio dei Carcinomi... and other collaborators

Terminated

CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients (CAPPA-2)

Non-Small Cell Lung Cancer

Italy
Mario Negri Institute for Pharmacological Research
Aventis Pharmaceuticals; Istituto Scientifico Romagnolo per lo Studio e la... and other collaborators

Completed

Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S)

Adenocarcinoma of the Gastroesophageal Junction | Adenocarcinoma of the Stomach

Italy
European Institute of Oncology
Associazione Italiana per la Ricerca sul Cancro

Completed

Continuous Observation of Smoking Subject (COSMOS)

Subjects at High Risk of Lung Cancer Due to Smoking

Italy
National Cancer Institute, Milan
Associazione Italiana per la Ricerca sul Cancro

Completed

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis

Liver Cirrhosis | Hepatocellular Carcinoma | Hepatitis C Virus Infection | Hepatic Resection | Interferon Treatment

Italy

Clinical Trials Sponsored by Istituto Auxologico Italiano

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations